Market closedNon-fractional
Zynex/ZYXI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Zynex
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Ticker
ZYXI
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Englewood, United States
Employees
1,100
Website
www.zynex.com
Zynex Metrics
BasicAdvanced
$324M
Market cap
43.11
P/E ratio
$0.24
EPS
0.54
Beta
-
Dividend rate
Price and volume
Market cap
$324M
Beta
0.54
Financial strength
Current ratio
3.585
Quick ratio
2.68
Long term debt to equity
215.619
Total debt to equity
227.897
Dividend payout ratio (TTM)
0.07%
Interest coverage (TTM)
7.24%
Management effectiveness
Return on assets (TTM)
5.81%
Return on equity (TTM)
16.75%
Valuation
Price to earnings (TTM)
43.108
Price to revenue (TTM)
1.861
Price to book
9.75
Price to tangible book (TTM)
67.67
Price to free cash flow (TTM)
21.013
Growth
Revenue change (TTM)
11.48%
Earnings per share change (TTM)
-48.31%
3-year revenue growth (CAGR)
28.45%
3-year earnings per share growth (CAGR)
18.75%
What the Analysts think about Zynex
Analyst Ratings
Majority rating from 4 analysts.
Zynex Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$47M
-1.48%
Net income
$0
-100.00%
Profit margin
0.00%
-100.00%
Zynex Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.09
$0.10
$0.21
-
-
Expected
$0.05
$0.09
$0.17
$0.03
$0.08
Surprise
100.00%
7.14%
23.53%
-
-
Zynex News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zynex stock?
Zynex (ZYXI) has a market cap of $324M as of July 27, 2024.
What is the P/E ratio for Zynex stock?
The price to earnings (P/E) ratio for Zynex (ZYXI) stock is 43.11 as of July 27, 2024.
Does Zynex stock pay dividends?
No, Zynex (ZYXI) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Zynex dividend payment date?
Zynex (ZYXI) stock does not pay dividends to its shareholders.
What is the beta indicator for Zynex?
Zynex (ZYXI) has a beta rating of 0.54. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Zynex stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.